A Clinico-Epidemiological Study of Cutaneous Adverse Drug Reactions in a Tertiary Care Centre of Eastern India

被引:0
作者
Sinha, Sujata [1 ]
Kar, Chinamy [1 ]
Das, Sudip [1 ]
Dutta, Arnab [1 ]
De, Abhishek [1 ]
机构
[1] Calcutta Natl Med Coll, Dept Dermatol, Kolkata, W Bengal, India
关键词
Antimicrobials; cutaneous adverse drug reactions; fixed drug eruption; EPIDERMAL NECROLYSIS; INPATIENTS;
D O I
10.4103/ijd.ijd_944_20
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Adverse drug reactions (ADRs) are major problems in the drug therapy. Cutaneous adverse drug reactions (CADRs) are the most common ADRs. The pattern of CADRs differs among various drugs. Aims: To record various morphological patterns of CADRs and their causal relationships among patients attending in a tertiary care centre. Materials and Methods: An observational, cross-sectional, clinical study was conducted for a duration of one and a half years in a tertiary care centre in eastern India. Patients presenting with suspected CADRs were included if drug identity could be ascertained. Clinical profiling and drug history were recorded, and causality assessment was carried out as per the Naranjo scale. Result: The commonest CADR in our study was fixed drug eruption (FDE) 48.61%, followed by SJS-TEN spectrum 16.66%, maculopapular rash 11.11% and so on. Severe cutaneous adverse drug reactions (SCARs) such as SJS, TEN, SJS-TEN Overlap, AGEP and DRESS accounted for 18 cases (25%). The most common culprit drugs were antimicrobials (54.16%), followed by nonsteroidal anti-inflammatory drugs (15.27%) and anticonvulsants (12.5%). Most of the CADRs were in probable category. Conclusion: The pattern of CADRs and the drugs causing them in our study population are similar to some previous studies but somewhat different from most of the previous Indian studies. The incidence of SCARs was significantly higher than in previous other studies in India and abroad.
引用
收藏
页数:7
相关论文
共 20 条
[1]  
Al-Raaie Faiza, 2008, Oman Med J, V23, P21
[2]  
ALANKO K, 1989, ACTA DERM-VENEREOL, V69, P223
[3]  
BIGBY M, 1986, JAMA-J AM MED ASSOC, V256, P3358
[4]  
Chatterjee S., 2006, Indian Journal of Pharmacology, V38, P429
[5]   Adverse drug reactions: definitions, diagnosis, and management [J].
Edwards, IR ;
Aronson, JK .
LANCET, 2000, 356 (9237) :1255-1259
[6]   Guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis: An Indian perspective [J].
Gupta, Lalit Kumar ;
Martin, Abhay Mani ;
Agarwal, Nidheesh ;
D'Souza, Paschal ;
Das, Sudip ;
Kumar, Rajesh ;
Pande, Sushil ;
Das, Nilay Kanti ;
Kumaresan, Muthuvel ;
Kumar, Piyush ;
Garg, Anubhav ;
Singh, Saurabh .
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2016, 82 (06) :603-625
[7]  
Hiware Sachin, 2013, Indian J Dermatol, V58, P18, DOI 10.4103/0019-5154.105279
[8]   Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury [J].
Kaniwa, Nahoko ;
Saito, Yoshiro .
JOURNAL OF HUMAN GENETICS, 2013, 58 (06) :317-326
[9]  
Nandha Ruchika, 2011, Int J Appl Basic Med Res, V1, P50, DOI 10.4103/2229-516X.81982
[10]   Retrospective analysis of Steven Johnson syndrome and toxic epidermal necrolysis over a period of 5 years from northern Karnataka, India [J].
Naveen, Kikkeri Narayanasetty ;
Pai, Varadraj V. ;
Rai, Vijetha ;
Athanikar, Sharatchandra B. .
INDIAN JOURNAL OF PHARMACOLOGY, 2013, 45 (01) :80-82